#prostatecancer 搜尋結果
There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm
Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.
Brilliant panel at #UromigosLive w an array of #ProstateCancer superstars, including my @cityofhope boss @TDorffOnc, @huntsmancancer program leader @neerajaiims, @ChrisSweens1, Morris & @charlesryanmd. @brian_rini doing an exceptional job navigating a complex discussion.…
The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…
The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…
If you, or a loved one, has been diagnosed with #ProstateCancer, our free One-to-One Peer Support service is like having a friend who gets it at the end of the phone. ➡️ Find out more: bit.ly/4id1x2F #MensHealth l #Support
Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻
Free tonight? In the Los Angeles area? Please come join our @cityofhope GU team leader @TDorffOnc for a terrific @OncLiveSOSS in Arcadia, CA covering NMIBC (@WesleyYipMD), #kidneycancer (@charlesbnguyen) & #prostatecancer (@arafflemd). Monday 11/17 at 5:30 pm - hope to see you…
New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…
🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025
3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ #NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita
Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! #Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda…
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR) ascopubs.org/doi/10.1200/JC… The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…
Meet #CamPROBE from @medovate a game-changer in prostate biopsies🔬 ✓ Lower infection risk ✓ Less invasive ✓ Simple to use ✓ Cost-effective Experience safer, more comfortable patient outcomes with our innovative transperineal biopsy device #ProstateDiagnostics #prostatecancer
1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum! Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. bit.ly/4nzJRyV Thanks to @LouiseKostos Heidi Fettke @PeterMacCC
#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
🚀 LUNAR phase II trial RCT of pts w/ oligorecurent hormone-sensitive #ProstateCancer 🖊️ @JCO_ASCO 🎯 Patients (n=92) randomized 1:1 to SBRT alone or ¹⁷⁷Lu-PNT2002 followed by SBRT ⭐️PFS doubled: 17.6 mo vs 7.4 months (HR 0.37, P<.0001) 📉 >50% PSA drops in 52% vs 31% 🧲…
Editor @msstaceyerin revisits a popular topic to see whether #regenerativemedicine is advancing #ProstateCancer research. Sprouting a ’stache is fun… but sprouting hope is even better. Comb through the full story signalsblog.ca/right-turn-bey… #Movember #MensHealth #CancerResearch
Not a single #Thanksgiving has gone by over the past decade when I haven’t been grateful for having my boss/ally/friend @TDorffOnc at @cityofhope. Beyond the incredible strides she has made in #immunotherapy for #prostatecancer, she has led our growing group with integrity,…
In the latest episode of On the Edge of Breakthrough, @montypal and @TDorffOnc discuss her pioneering work in immunotherapy for prostate cancer, the importance of collaborative team-science, and so much more! Watch and subscribe: bit.ly/3M0bK6l
Visit Oncotarget's Special Collection on Prostate Cancer: oncotarget.com/collections/pr… #prostatecancer #cancerresearch #cancer #openaccess #publishing
#prostatecancer Coping with #Cancer amazon.com/dp/B09P7LZJTQ/
🔗 AFU recommendations for #prostatecancer 2025 (summary of changes): doi.org/10.1016/j.fjur… 🔗 PRIME in @JAMA_current: doi.org/10.1001/jama.2… #UroSoMe #prostateMRI #EMUC25
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? @CaPsurvivorship shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedX #ProstateCancer #Movember ow.ly/ap8W50XyGu2
Looking to speak to black men about #prostatecancer awareness and screening in the UK - for a sensitive Men's Health magazine piece. Can be anon. Please email [email protected] #journorequest #blacktwitter
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model nature.com/articles/s4139… In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…
New therapeutic strategies show promise against a hard-to-treat prostate cancer. ow.ly/r3NC50XyCn3 #ProstateCancer #CancerResearch #Oncology #CancerAwareness #CancerTreatment
It's absolutely right the the UK National Screening Committee get hold of prostate cancer screening & implement it ASAP. The SoS for Health @wesstreeting @DHSCgovuk @NHSuk need to push hard for this. #prostatecancer
📢 There’s still time to sign up! Men across Greater Manchester are invited to our online prostate cancer focus group. 🗓 Fri 28 Nov 2025 🕚 11:30am 💻 Microsoft Teams 👉 Call 0161 253 6300 or email [email protected] #prostatecancer
📝Access mCRPC treatment guidance in seconds with @ONCOassist This tool presents efficacy data from recent trials of novel treatments for patients with mCRPC. #mCRPC #ProstateCancer #OncologyTools #CancerCare #ClinicalOncology #DigitalHealth #OncologyApp…
Prostate cancer hits thousands of men in the UK every year - and most cases caught early are treatable. This design is a reminder: lads, stop ignoring the check-ups. Awareness saves lives. 💙 #ProstateCancer #MensHealth #BlueRibbon
A new study suggests many men with prostate cancer may not need long-term hormone therapy. Researchers found most ADT benefits happen in the first 9–12 months. Smarter treatment, fewer side effects. #ProstateCancer #CancerResearch #TCSC #Oncology #Cancer newsroom.ucla.edu/releases/long-…
👨⚕️ Prostate cancer is the most common cancer in men. Spotify: bit.ly/41vadZU Apple: bit.ly/4h9OsF1 Amazon: bit.ly/4i5B99Y YouTube: bit.ly/4ktGnhm #ProstateCancer #Movember #MensHealth #ProstateCancerAwarenessMonth #CancerPodcast
youtube.com
YouTube
Episode 11: Standing up to prostate cancer
C'mon, chop, chop! Get #ProstateCancer screening up & running! We MUST commence working towards making vast reductions in the number of men diagnosed 'incurable', then the same for 'Aggressive PCa'. The vision must be 80% are treated through Focal Therapy, by 2036.
Screening smartly catches aggressive cancers early when they're highly curable & with less side effects, while avoiding unnecessary tests, biopsies and anxiety for those at low risk says @marclaniado dailymail.co.uk/news/article-1…
3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer
⚕ A quick #PSA blood test could help catch prostate cancer early. Men 50+: make PSA screening a yearly habit. 📍PSA Test bhx.one/PBc6Mh 📍Urology Center bhx.one/rvw4AR 📍Packages bhx.one/RZPaKg #ProstateCancer #MensHealth #EarlyDetection #Bumrungrad
🧔♂️ November is #Movember – raising awareness for #MensHealth & #ProstateCancer. At #OPTIMA, we're using #AI & #RealWorldData to support better, personalised care. Early detection saves lives. Let's talk, share, and support innovation in cancer care. #AIforCancer #CancerCare
The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…
Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! #Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda…
New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…
🚨23 years of PSA screening in @NEJM 🚨 👉ERSPC RCT of >162k patients 📅Median 23 year f/u PSA screening lead to... 📉 #prostatecancer mortality by 13% ✅1 death prevented for every 456 men invited for screening or 12 diagnosed w/ PCa 📉Risk of advanced PCa by 34% ⭐️Benefit…
Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.
🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025
🚨ENZARAD at #ESMO25 presented by @DrPaulNguyen No improvement in MFS or OS with the addition of enzalutamide to high dose radiotherapy + 2y ADT in high risk #prostatecancer Possible benefit in cN1 pts or pts treated with pelvic RT.
1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum! Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. bit.ly/4nzJRyV Thanks to @LouiseKostos Heidi Fettke @PeterMacCC
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR) ascopubs.org/doi/10.1200/JC… The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…
Five years on, we’re celebrating the life and legacy of our incredible ambassador and friend, #RayClemence 💙 A true @England legend, Ray faced #ProstateCancer for more than 15 years with remarkable courage and compassion, all while tirelessly supporting our work.
The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…
There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm
Metformin Active Surveillance Trial in Low-Risk Prostate Cancer ascopubs.org/doi/abs/10.120… The phase III Metformin Active Surveillance Trial (MAST) evaluated whether metformin could delay disease progression in men with low-risk, localized #ProstateCancer managed with active…
John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪 The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way. He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
Novembre, mese della prevenzione maschile. Cerchiamo di ricordare all’opinione pubblica e ai colleghi che la radioterapia nel tumore della prostata e’ una opzione non invasiva e altrettanto efficace! #movember #ProstateCancer #radonc
European Study of Prostate Cancer Screening — 23-Year Follow-up nejm.org/doi/full/10.10… The 23-year follow-up of the European Randomized Study of Screening for #ProstateCancer (ERSPC) confirms that PSA-based screening yields a sustained reduction in prostate cancer mortality.…
Simulation-free radiotherapy on the MR-linac in prostate cancer academic.oup.com/bjr/article/98… This study examined whether diagnostic MRI (dMRI) scans could replace dedicated simulation imaging for planning MRI-guided adaptive radiotherapy (MRIgART) in #ProstateCancer . Reviewing…
#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced #ProstateCancer link.springer.com/article/10.100… This paper discusses the emerging role of PSMA-PET/CT and whole-body MRI (WB-MRI) in prostate cancer, emphasizing their superior accuracy over conventional CT and bone…
Something went wrong.
Something went wrong.
United States Trends
- 1. Thanksgiving 1.76M posts
- 2. Chiefs 86.4K posts
- 3. Chiefs 86.4K posts
- 4. Mahomes 27.3K posts
- 5. George Pickens 14.2K posts
- 6. Sarah Beckstrom 116K posts
- 7. McDuffie 6,600 posts
- 8. Post Malone 4,847 posts
- 9. Tony Romo 3,112 posts
- 10. #KCvsDAL 8,927 posts
- 11. Turpin 1,913 posts
- 12. #AEWCollision 4,211 posts
- 13. Joe Burrow 7,774 posts
- 14. Spags 2,056 posts
- 15. Lions 102K posts
- 16. Dak Prescott 7,152 posts
- 17. #RavensFlock 2,018 posts
- 18. Andy Reid 2,091 posts
- 19. Kelce 14.3K posts
- 20. Derrick Henry 1,949 posts